Active substances
Caffeine + Paracetamol
- SFDA 7
- Health Canada 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ADOL EXTRA CAPLETS | 500,60 mg,mg | Caplet · Oral use | 24 Blister | SAR 6.40 | Generic · OTC | GULF PHARMACEUTICAL INDUSTIRES- JULPHAR | Valid |
| FEVADOL EXTRA TAB. | 500,65 mg,mg | Tablet · Oral use | 30 Blister | SAR 8.70 | Generic · OTC | SPIMACO ADDWAEIH | Valid |
| MIDRONE EXTRA TAB | 500,60 mg,mg | Tablet · Oral use | 30 Blister | SAR 5.75 | Generic · OTC | Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co. | Valid |
| OMOL EXTRA TABLETS | 500,65 mg,mg | Tablet · Oral use | 20 Blister | SAR 3.85 | Generic · OTC | National Pharmaceutical Industries Co. (SAOG) | Valid |
| PANADOL EXTRA TAB | 500,65 mg,mg | Tablet · Oral use | 24 Blister | SAR 8.00 | NCE · OTC | GLAXOSMITHKLINE (GSK) | Valid |
| PANDA EXTRA CAPLETS | 500,65 mg,mg | Tablet · Oral use | 24 Blister | SAR 4.65 | Generic · OTC | Jordan Sweden Medical and Sterilization Co. | Valid |
| AMOL EXTRA TABLETS | 500, 65 mg | Tablet · Oral use | 20 Blister | SAR 4.20 | Generic · OTC | SHAPHACO PHARMACEUTICAL | Suspended · Not Marketed |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| EXTRA STRENGTH TYLENOL DAYTIME RELIEF | 02544687 | 65 MG; 500 MG | TABLET · ORAL | KENVUE CANADA INC. |
| TYLENOL ULTRA RELIEF | 02254468 | 65 MG; 500 MG | TABLET · ORAL | KENVUE CANADA INC. |
| ULTRA HEADACHE RELIEF | 02264870 | 65 MG; 500 MG | TABLET · ORAL | VITA HEALTH PRODUCTS INC |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.